Dihydroxyphenylglycine
Dihydroxyphenylglycine (DHPG) is a chemical compound that is used in the field of neuroscience to study the function of glutamate receptors. It is a potent and selective agonist for the group I metabotropic glutamate receptors (mGluR).
Chemical Structure[edit]
DHPG is a derivative of the amino acid phenylalanine. It has two hydroxyl groups attached to the phenyl ring, and a carboxyl group and an amino group at the alpha carbon. The presence of the hydroxyl groups makes DHPG a polar molecule, which allows it to interact with the protein structure of the mGluR.
Pharmacological Properties[edit]
DHPG is a potent agonist for the group I mGluR, which includes mGluR1 and mGluR5. These receptors are G protein-coupled receptors that are activated by the neurotransmitter glutamate. Activation of these receptors by DHPG can lead to various cellular responses, including the release of calcium ions from intracellular stores and the activation of phospholipase C.
Applications in Neuroscience[edit]
In neuroscience research, DHPG is often used to study the function of the group I mGluR. For example, it can be used to investigate the role of these receptors in synaptic plasticity, a process that is crucial for learning and memory. DHPG can also be used to study the involvement of the group I mGluR in neurological and psychiatric disorders, such as schizophrenia and depression.
Safety and Toxicity[edit]
As with any chemical compound, DHPG should be handled with care. It can cause irritation to the skin and eyes, and it can be harmful if swallowed or inhaled. Appropriate safety measures should be taken when handling DHPG, including the use of personal protective equipment.
-
Dihydroxyphenylglycine biosynthesis part 1
-
Dihydroxyphenylglycine biosynthesis part 2
-
Dihydroxyphenylglycine biosynthesis part 3
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian

